v3.25.2
Net Loss Per Share (Tables)
6 Months Ended
Jun. 30, 2025
Earnings Per Share [Abstract]  
Schedule of Anti-dilutive Equity Instruments Excluded from Calculation of Diluted Net Loss Per Share

The following equity instruments were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive for the periods presented:

 

 

 

Six months ended June 30,

 

 

 

2025

 

 

2024

 

Awards under equity incentive plan

 

 

13,189,871

 

 

 

9,735,019

 

Non-vested restricted shares and restricted stock units

 

 

4,043,000

 

 

 

3,560,125

 

Warrants to purchase common stock(*)

 

 

77,793

 

 

 

77,793

 

Total

 

 

17,310,664

 

 

 

13,372,937

 

* Pre-funded warrants are excluded herein.

Reconciles Basic Earnings Per Share and Diluted Earnings Per Share of Common Stock

The following table calculates basic earnings per share of common stock and diluted earnings per share of common stock for the three and six months ended June 30, 2025 and 2024 (in thousands, except share and per share amounts):

 

 

 

Three months ended June 30,

 

 

Six months ended June 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Net loss

 

$

(30,401

)

 

$

(22,243

)

 

$

(57,040

)

 

$

(42,589

)

Net loss attributable to common
   stockholders

 

 

(30,401

)

 

 

(22,243

)

 

 

(57,040

)

 

 

(42,589

)

Undistributed earnings and net loss
   attributable to common stockholders,
   basic and diluted

 

 

(30,401

)

 

 

(22,243

)

 

 

(57,040

)

 

 

(42,589

)

Weighted-average common shares
   outstanding, basic and diluted

 

 

216,431,348

 

 

 

182,584,078

 

 

 

216,289,923

 

 

 

182,567,091

 

Basic and diluted net loss per share

 

$

(0.14

)

 

$

(0.12

)

 

$

(0.26

)

 

$

(0.23

)